This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
ISM Services Index Rebounds in October: 5 Top-Ranked Picks
by Nalak Das
The ISM Services index clearly reflects that the U.S. economy has sustained its momentum despite lingering trade conflict and global economic slowdown.
Tenet Healthcare (THC) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings gain from its Hospital and Other segment as well as volume growth.
Find Strong Buy Stocks Hitting New Highs with this Stock Screener
by Benjamin Rains
The most basic idea is that the winners in your portfolio are the stocks going up. So here is how to find strong buy stocks hitting new highs...
Tenet Healthcare (THC) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 107.14% and 2.39%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare ETF (IHF) Tops in October: 5 Best Stocks
by Sweta Killa
Inside the best performing stocks of the top ETF of October.
What to Expect From Tenet Healthcare's (THC) Q3 Earnings
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results are likely to reflect weaker revenues, partially offset by higher contribution from its Conifer segment.
HCA Healthcare (HCA) Catches Eye: Stock Jumps 6.4%
by Zacks Equity Research
HCA Healthcare (HCA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Earnings Preview: Tenet Healthcare (THC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
5 Safe Stocks to Counter IMF's Dull Global Economic Outlook
by Zacks Equity Research
Global economy is slowing down and IMF has turned pessimistic. This is the perfect time for investors to go defensive and invest in these five stocks.
Humana to Provide Florida's Retirees With Medicare Plans
by Zacks Equity Research
Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.
New Strong Buy Stocks for October 15th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
MEDNAX (MD) to Sell MedData for Focusing on Core Business
by Zacks Equity Research
MEDNAX (MD) to divest its billing services business for streamlining its operations.
Humana's New Plans to Complement VA Healthcare Coverage
by Zacks Equity Research
Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.
Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag
by Zacks Equity Research
Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.
Hospital Industry Outlook: Rising Baby Boomers to Drive Growth
by Sapna Bagaria
The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.
Tenet (THC) Down 2.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Pick Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Let's see if Tenet Healthcare (THC) stock is a good choice for value-oriented investors right now from multiple angles.
Tenet Healthcare's Senior Secured Notes Get Rating Actions
by Zacks Equity Research
Tenet Healthcare's (THC) new senior secured first lien notes receive rating affirmations from Moody's. Outlook is stable.
Tenet Healthcare (THC) Q2 Earnings Top Estimates & Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings gain on the back of its Hospital and Other segment and volume growth.
Tenet Healthcare (THC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 27.27% and 1.69%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Tenet Healthcare (THC) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings are likely to suffer due to lower revenues.
Analysts Estimate Tenet Healthcare (THC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q2 earnings are likely to be aided by higher admissions and revenues, partly offset by escalating expenses.
WellCare Health's (WCG) Q2 Earnings: What's in Store?
by Zacks Equity Research
WellCare Health's (WCG) Q2 earnings are likely to be supported by higher membership.